Keensight Capital, one of the largest private equity managers dedicated to European Growth Buyout investments, raised €2.8 billion in funds to invest in leading technology and healthcare companies.
Keensight Capital received support from existing LPs, as well as new investors from Europe, North America, the Middle East, and Asia. This globally diverse LP base generated c.90% of subscriptions from institutional investors (asset managers, pension funds, insurance companies, banks and sovereign wealth funds), and c.10% from former portfolio company CEOs and family offices.
Keensight Capital will continue to pursue its investment strategy as a partner to entrepreneurs of companies benefiting from profitable growth, and generating revenues in the range of €10m to €400m.
The firm makes investments in profitable, private companies experiencing strong growth, in minority or majority positions, with or without leverage, using a flexible approach tailored to the needs of individual entrepreneurs, in order to finance organic growth projects, acquisition strategies or provide historic shareholders with liquidity.
Since its creation over 20 years ago, the team, today comprised of 80 people, has invested in 69 companies and completed 48 exits, generating an overall gross IRR of 39% and an average gross multiple of 3.4x. Keensight’s portfolio companies have achieved an average annual sales growth rate of 20% over the last 5 years and an average EBITDA margin of 25% in 2022, proof that Keensight has generated value through profitable growth independent of market cycles.
FinSMEs
22/09/2023